World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
18296
World Ranking
14173
National Ranking
5976

Philippe Gallay publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Philippe Gallay sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 169 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Philippe Gallay D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Philippe Gallay sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 56 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Philippe Gallay is affiliated with the Scripps Research Institute in the United States and has produced a significant body of research bridging medicine, biochemistry, genetics, and molecular biology. Their work is particularly concentrated in infectious diseases, molecular biology, epidemiology, virology, and immunology.

Their research topics include:

  • Signaling Pathways in Disease
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • SARS-CoV-2 detection and testing
  • Peptidase Inhibition and Analysis

Gallay has contributed articles to various publication venues, with multiple works appearing in:

  • Journal of Hepatology
  • PLoS ONE
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • Antiviral Research

Their recent published papers include:

  • A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents, 2021, Antiviral Research
  • Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro, 2021, Antiviral Research
  • Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice, 2021, Viruses
  • Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis, 2020, Frontiers in Pharmacology
  • Cyclophilin inhibition as a strategy for the treatment of human disease, 2024, Frontiers in Pharmacology

Frequent co-authors working alongside Gallay include:

  • Michael Bobardt
  • Daren Ure
  • Winston T Stauffer
  • Joseph Kuo
  • Robert T. Foster

Best Publications

  • In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

    Luigi Naldini;Ulrike Blömer;Philippe Gallay;Daniel Ory

  • HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.

    Philippe Gallay;Thomas Hope;Daniel Chin;Didier Trono

  • Vector and method of use for nucleic acid delivery to non-dividing cells

    Inder Verma;Didier Trono;Luigi Naldini;Philippe Gallay

  • HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase

    Philippe Gallay;Simon Swingler;Jinping Song;Frederic Bushman

  • HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator

    Philippe Gallay;Simon Swingler;Christopher Aiken;Didier Trono

  • Interferon gamma receptor deficient mice are resistant to endotoxic shock

    B. D. Car;V. M. Eng;B. Schnyder;L. Ozmen

  • Active site residues of cyclophilin A are crucial for its signaling activity via CD147.

    Vyacheslav Yurchenko;Gabriele Zybarth;Matthew O'Connor;Wei Wei Dai

  • Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.

    P Gallay;V Stitt;C Mundy;M Oettinger

  • Syndecans Serve as Attachment Receptors for Human Immunodeficiency Virus Type 1 on Macrophages

    Andrew C. S. Saphire;Michael D. Bobardt;Zhe Zhang;Guido David

  • The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.

    Robert Flisiak;Andrzej Horban;Philippe Gallay;Michael Bobardt

  • Syndecan Captures, Protects, and Transmits HIV to T Lymphocytes

    Michael D Bobardt;Andrew C.S Saphire;Hsiu-Cheng Hung;Xiaocong Yu

  • The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication

    Udayan Chatterji;Michael Bobardt;Suganya Selvarajah;Feng Yang

  • Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.

    D Heumann;P Gallay;C Barras;P Zaech

  • Host cyclophilin A mediates HIV-1 attachment to target cells via heparans

    Andrew C.S. Saphire;Michael D. Bobardt;Philippe A. Gallay

  • Cell-Free Human Immunodeficiency Virus Type 1 Transcytosis through Primary Genital Epithelial Cells

    Michael D. Bobardt;Udayan Chatterji;Suganya Selvarajah;Bernadette Van der Schueren

  • DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A

    Lotte Coelmont;Xavier Hanoulle;Udayan Chatterji;Carola Berger

  • Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1

    Lot de Witte;Michael Bobardt;Udayan Chatterji;Gisèle Degeest

  • HCV RESISTANCE TO CYCLOSPORIN A DOES NOT CORRELATE WITH A RESISTANCE OF THE NS5A-CYCLOPHILIN A INTERACTION TO CYCLOPHILIN INHIBITORS

    Udayan Chatterji;Precious Lim;Michael D. Bobardt;Stefan Wieland

  • Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock

    P Gallay;D Heumann;D Le Roy;C Barras

  • TNF-α and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo

    Marein A.W.P. de Jong;Lot de Witte;Menno J. Oudhoff;Sonja I. Gringhuis

Frequent Co-Authors

Didier Trono
Didier Trono École Polytechnique Fédérale de Lausanne
Johan Neyts
Johan Neyts Rega Institute for Medical Research
Luigi Naldini
Luigi Naldini Vita-Salute San Raffaele University
Guido David
Guido David KU Leuven
Barrie Wilkinson
Barrie Wilkinson John Innes Centre
Michel P. Glauser
Michel P. Glauser University Hospital of Lausanne
Inder M. Verma
Inder M. Verma Salk Institute for Biological Studies
Nikolai V. Naoumov
Nikolai V. Naoumov Novartis (Switzerland)
Pieter Leyssen
Pieter Leyssen Rega Institute for Medical Research
Christopher Aiken
Christopher Aiken Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA can open doors to a wide range of online degrees and careers in health and life sciences. Today, students can access flexible learning options, combining their scientific background with specialized online programs.

For those interested in healthcare administration and data, earning a him degree is a popular pathway. This qualification helps graduates manage medical records and maintain patient privacy.

Another option is medical coding, which lets professionals work remotely while interpreting patient information. If you're wondering is medical coding a good job, it's important to consider factors like demand, salary, and career growth.

Nutrition is an in-demand field for science graduates. Many opt for online master’s degrees. To control costs, consider pursuing the cheapest online master's in nutrition.

For those drawn to diagnostic technologies, check out online sonography certificate programs for fast, accredited training. These programs help you join the fast-evolving healthcare sector in just a few months.

Best Scientists Citing Philippe Gallay

Trending Scientists

Recently Published Articles